Table 1.
Clinicopathological features of patients in different datasets
| Variables | GSE130970 | GSE126848 | |||||
|---|---|---|---|---|---|---|---|
| NT | NAFL | NASH | NT | Obesity | NAFL | NASH | |
| Age (years) | |||||||
| Mean | 53 | 50.5 | 53.9 | / | / | / | / |
| Gender | |||||||
| Male | 1 | 5 | 9 | 14 | 12 | 9 | 12 |
| Female | 3 | 5 | 17 | 0 | 0 | 6 | 4 |
| Lobular inflammation grade | |||||||
| 0 | 4 | 3 | 0 | / | / | / | / |
| 1 | 0 | 7 | 18 | / | / | / | / |
| 2 | 0 | 0 | 8 | / | / | / | / |
| Cytological ballooning grade | |||||||
| 0 | 4 | 10 | 1 | / | / | / | / |
| 1 | 0 | 0 | 7 | / | / | / | / |
| 2 | 0 | 0 | 18 | / | / | / | / |
| Steatosis grade | |||||||
| 0 | 4 | 0 | 0 | / | / | / | / |
| 1 | 0 | 9 | 2 | / | / | / | / |
| 2 | 0 | 1 | 13 | / | / | / | / |
| 3 | 0 | 0 | 11 | / | / | / | / |
| Fibrosis stage | |||||||
| 0 | 4 | 7 | 1 | / | / | / | / |
| 1 | 0 | 3 | 12 | / | / | / | / |
| 2 | 0 | 0 | 4 | / | / | / | / |
| 3 | 0 | 0 | 8 | / | / | / | / |
| 4 | 0 | 0 | 1 | / | / | / | / |
| NAFLD activity score | |||||||
| NAS = 0 | 4 | 0 | 0 | / | / | / | / |
| 0 < NAS < 3 | 0 | 10 | 0 | / | / | / | / |
| NAS ≥ 5 | 0 | 0 | 26 | / | / | / | / |